On May 20, 2014, the Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents was updated. The correction was made to Table 6. Recommended and Alternative Antiretroviral Regimen Options for Treatment-Naive Patients, which can be found in the What to Start: Initial Combination Regimens for the Antiretroviral-Naive Patient section of the guidelines. The INSTI-based regimen listed at the bottom of the table—RAL plus ABC/3TC (BII), only for patients who are HLA-B*5701 negative—was amended to include the following footnote:
3TC may be substituted for FTC or vice versa. The following combinations in the recommended list above are available as co-formulated fixed-dose combinations: ABC/3TC, EFV/TDF/FTC, EVG/cobi/TDF/FTC, LPV/r, RPV/TDF/FTC, and TDF/FTC.
Please see the Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents to view the update.